NCT04926623 - Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) | Biotech Hunter

Enrollment

159

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

October 26, 2022

Study Completion Date

April 4, 2023

Conditions

Type 2 Diabetes Mellitus

Interventions

DEVICE

FreeStyle Libre 24 weeks

FreeStyle Libre flash sensor-based glucose monitoring system (FSGM; Abbott Diabetes Care, Witney, Oxon, UK)

OTHER

SMBG (22 weeks) and blind CGM (2 weeks)

Self-Monitoring of Blood Glucose and Continuous Glucose Monitoring

Trial Locations (1)

Samsung Medical Center, Seoul